POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces
NCT ID: NCT03781453
Last Updated: 2020-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
498 participants
INTERVENTIONAL
2019-04-01
2020-02-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Multi-Modal Workplace Rest Cabin on Worker Well-Being
NCT07322354
An Integrated Approach to Health, Wellbeing, and Productivity at Work
NCT05866978
Effects of Motivational Interviewing for Long-term Sick Absence
NCT03212118
Effects of a Self-management Course for Adults on Sick-leave
NCT02136056
MANAGE AT WORK: Addressing the Challenge of Chronic Physical Health Conditions in the Workplace
NCT01978392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
POWERPLAY
Employees from participating worksites will be invited to completed surveys prior to and following implementation of a workplace wellness program (called "POWERPLAY")
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Athabasca University
OTHER
University of Alberta
OTHER
Newcastle University
OTHER
University of Melboune
UNKNOWN
University Technology Sydney
UNKNOWN
Joan Bottorff
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joan Bottorff
Professor and Director of the Institute for Healthy Living and Chronic Disease Prevention
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shell Canada Ltd (Scotford Site)
Ft Saskatchewan, Alberta, Canada
Roper Ventures
Rocky Mountain House, Alberta, Canada
PeroxyChem
Prince George, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
POWERPLAY program website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
095244772
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.